What is Lymphedema?
Lymphedema occurs when the lymphatic system — the network of vessels, nodes, and organs responsible for draining excess fluid from the body’s tissues — is damaged, obstructed, or congenitally underdeveloped. When lymphatic drainage is impaired, protein-rich lymphatic fluid accumulates in the interstitial spaces of affected tissues, causing progressive swelling, chronic inflammation, and, over time, fibrotic changes to the skin and subcutaneous tissue.
Lymphedema is classified as either primary or secondary. Primary lymphedema results from congenital abnormalities of the lymphatic system — either underdevelopment (hypoplasia), absence, or malformation of lymphatic vessels or nodes — and may be present at birth or manifest at puberty or in early adulthood. Secondary lymphedema is far more common and develops as a consequence of damage to the lymphatic system from an external cause. In developed countries, cancer treatment — particularly the surgical removal of lymph nodes and radiation therapy — is the leading cause of secondary lymphedema. Worldwide, filariasis (a parasitic infection) remains the most common cause.
Lymphedema is a lifelong condition that is not curable but is highly manageable with early diagnosis and consistent treatment. Without appropriate care, lymphedema progresses, skin changes develop, and the risk of serious skin infections (cellulitis) increases substantially. At Vascular Surgical Associates, we provide the comprehensive evaluation needed to accurately diagnose and stage lymphedema, identify contributing vascular factors, and build a personalized management plan that gives patients the best possible long-term outcomes.
Signs & Symptoms
Lymphedema symptoms typically develop gradually, though secondary lymphedema after cancer surgery may appear within months of treatment. Early recognition and intervention are essential to preventing progression and complications.
Persistent Limb Swelling
Progressive, non-pitting or pitting swelling of an arm, leg, hand, or foot that does not fully resolve with elevation, the hallmark sign of lymphedema and the primary driver of evaluation.
Heaviness & Tightness
A persistent sense of heaviness, fullness, or tightness in the affected limb, often accompanied by aching discomfort that worsens with activity or toward the end of the day.
Reduced Range of Motion
Progressive swelling and tissue fibrosis in the affected limb can restrict joint mobility, reducing the range of motion of the shoulder, elbow, wrist, knee, or ankle and impairing daily function.
Skin Changes
The skin overlying lymphedematous tissue becomes thickened, leathery, and hyperkeratotic over time. Skin folds deepen, particularly around the ankle and foot, and the skin may take on a cobblestone or wart-like texture in advanced stages.
Recurrent Skin Infections (Cellulitis)
Protein-rich stagnant lymph provides an excellent medium for bacterial growth. Patients with lymphedema are at significantly elevated risk of recurrent skin infections (cellulitis) that cause redness, warmth, and fever, and each episode worsens underlying lymphatic damage.
Positive Stemmer Sign
The inability to pinch and lift a fold of skin at the base of the second toe or finger — the Stemmer sign — is a pathognomonic physical finding in lymphedema that distinguishes it from other causes of limb swelling, including venous edema and lipedema.
Stages of Lymphedema
The International Society of Lymphology classifies lymphedema into four stages. Early-stage lymphedema is more responsive to conservative management; advanced stages require more intensive treatment to prevent further tissue damage.
Subclinical / Latent
Lymphatic transport is impaired but swelling is not yet visible. Patients may notice subtle heaviness. Early intervention at this stage can prevent progression to overt lymphedema.
Reversible Swelling
Swelling is present and pits with pressure. It partially or fully resolves with elevation overnight. No skin changes are present. The condition is most responsive to treatment at this stage.
Spontaneously Irreversible
Swelling does not resolve with elevation. Fibrotic skin changes begin to develop. Pitting may or may not be present. Consistent CDT and compression are essential to prevent progression.
Lymphostatic Elephantiasis
Severe, non-pitting swelling with major skin changes including hyperkeratosis, deep skin folds, and papillomatosis. Significant functional impairment and high infection risk characterize this advanced stage.
Common Causes & Risk Factors
Cancer Treatment
Surgical removal of lymph nodes and radiation therapy — particularly for breast, gynecological, prostate, melanoma, and head and neck cancers — are the most common causes of secondary lymphedema in the United States.
Infection & Inflammation
Recurrent episodes of cellulitis progressively damage lymphatic vessels, and repeated infections can convert a mild lymphatic impairment into established lymphedema even without prior cancer treatment.
Chronic Venous Insufficiency
Longstanding venous hypertension overwhelms the lymphatic system’s capacity to drain fluid from the lower extremities, leading to a combined condition called phlebolymphedema that requires management of both the venous and lymphatic components.
Obesity
Excess body weight compresses lymphatic vessels and increases the volume of fluid that the lymphatic system must manage, significantly raising the risk of lymphedema and accelerating progression in those who already have compromised lymphatic function.
Trauma or Surgery
Injury, burns, or surgical procedures that disrupt lymphatic channels in the extremities or trunk can result in secondary lymphedema, even in the absence of cancer-related lymph node removal.
Congenital Lymphatic Anomalies
Primary lymphedema results from developmental abnormalities of the lymphatic system and may present at birth (Milroy disease), at puberty (lymphedema praecox), or in adulthood (lymphedema tarda), often with a familial pattern.
Evaluation at VSA
A thorough lymphedema evaluation at Vascular Surgical Associates begins with a detailed clinical history, including prior surgeries, cancer treatments, infections, travel history, and the timeline and pattern of swelling. Physical examination assesses the distribution of swelling, skin integrity, the presence of the Stemmer sign, and limb circumference measurements that provide a quantitative baseline for tracking treatment response.
Because venous disease frequently coexists with or mimics lymphedema, duplex ultrasound of the venous system is an integral part of our evaluation. Identifying concurrent chronic venous insufficiency, deep vein thrombosis, or venous obstruction is essential, as these venous factors must be addressed alongside lymphedema management to achieve optimal outcomes. Left untreated, venous hypertension will continue to overwhelm even well-managed lymphatic drainage.
When the diagnosis is uncertain, or when surgical lymphatic reconstruction is being considered, specialized lymphatic imaging studies are coordinated. Lymphoscintigraphy — a nuclear medicine scan that traces the movement of radiolabeled tracer through the lymphatic channels — provides a functional map of lymphatic drainage and quantifies the degree of lymphatic impairment. Indocyanine green (ICG) lymphography and MR lymphangiography may also be used to provide detailed anatomical imaging of the lymphatic vessels in preparation for microsurgical procedures. All findings are reviewed by our experienced vascular team to develop an individualized, evidence-based treatment plan.
Management & Treatment
Lymphedema management is lifelong and requires consistent, active participation from the patient. Our team coordinates across specialties to provide comprehensive, evidence-based care that reduces limb volume, prevents complications, and supports quality of life at every stage.
Complete Decongestive Therapy (CDT)
CDT is the gold-standard treatment for lymphedema and consists of two phases. The intensive phase — performed by a certified lymphedema therapist — uses manual lymphatic drainage (MLD), multilayer compression bandaging, therapeutic exercise, and meticulous skin care to achieve maximum volume reduction. The maintenance phase involves transitioning to compression garments, self-administered MLD, and a home exercise program to preserve the gains achieved during intensive therapy. CDT is appropriate for patients at all stages and is the foundation upon which all other treatments are built.
Medical-Grade Compression Garments & Devices
Long-term use of properly fitted compression garments is essential to maintaining lymphedema control after CDT. Flat-knit custom garments provide the consistent, graduated compression needed to prevent reaccumulation of lymphatic fluid and protect skin integrity. Pneumatic compression devices — sequential compression pumps worn at home for daily sessions — augment manual drainage and are particularly beneficial for patients with moderate to advanced lymphedema. Our team coordinates garment fitting and prescription, with regular reassessment as limb volume changes.
Lymphatic Microsurgery
For carefully selected patients with early-stage lymphedema who have not responded adequately to conservative management, surgical options have advanced significantly. Lymphaticovenous anastomosis (LVA) — a microsurgical procedure that creates connections between lymphatic channels and small veins to bypass damaged lymphatic segments — can reduce limb volume and decrease the frequency of infections in appropriate candidates. Vascularized lymph node transfer (VLNT) transplants healthy lymph nodes from a donor site to the affected region to stimulate lymphangiogenesis and restore drainage. Our team coordinates surgical consultation with experienced microsurgeons when these options are appropriate.
Venous Treatment & Wound Care
When chronic venous insufficiency contributes to or coexists with lymphedema (phlebolymphedema), treating the underlying venous disease — through ablation, compression, or other vascular interventions — significantly reduces the fluid load on the impaired lymphatic system and improves overall limb health. For patients who develop chronic wounds or skin breakdown from advanced lymphedema, our Wound 360 team provides specialized wound care integrated with lymphedema management to promote healing and prevent infection.
Frequently Asked Questions
Lymphedema is not curable with current treatments, as damaged lymphatic vessels cannot fully regenerate. However, it is highly manageable. With early diagnosis, consistent CDT, diligent compression use, and appropriate lifestyle modifications, most patients achieve significant volume reduction and can maintain stable, well-controlled lymphedema over the long term. Emerging microsurgical techniques offer the possibility of meaningful long-term improvement in carefully selected early-stage patients, and the field continues to advance rapidly.
Ordinary swelling (edema) from causes such as sitting too long, a minor ankle sprain, or heat is typically mild, symmetric, and resolves readily with elevation and rest. Lymphedema, in contrast, is persistent, progressive, and does not fully resolve with elevation. It has a characteristic distribution, is associated with a positive Stemmer sign, and eventually produces fibrotic skin changes that distinguish it from simple fluid accumulation. Venous edema — from chronic venous insufficiency — can closely mimic lymphedema and frequently coexists with it, which is why a full vascular evaluation is important.
Yes — lymphedema of the arm is a well-recognized risk following axillary lymph node dissection or sentinel lymph node biopsy for breast cancer, occurring in approximately 15–40% of patients depending on the extent of surgery and whether radiation was used. The risk is highest in patients who had more extensive lymph node removal, axillary radiation, postoperative infection, or higher body weight. Pre- and post-operative screening with limb volume measurements and early intervention at Stage 0 (before swelling appears) has been shown to substantially reduce the likelihood of progression to established lymphedema.
The frequency of follow-up depends on the stage of lymphedema, the treatment phase, and the presence of complicating factors such as venous disease or recurrent infections. During the intensive CDT phase, patients typically see their lymphedema therapist multiple times per week. Once stable on a home maintenance program, our vascular team sees patients every three to six months to assess limb volume, evaluate garment fit, and adjust the management plan as needed. Patients are encouraged to seek prompt evaluation for any signs of cellulitis, sudden worsening of swelling, or new skin changes between scheduled visits.